Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry

Takaya Moriyama, Yung-Li Yang, Rina Nishii, Hany Ariffin, Chengcheng Liu, Ting-Nien Lin, Wenjian Yang, Dong-Tsamn Lin, Chih-Hsiang Yu, Shirley Kham, Ching-Hon Pui, William E. Evans, Sima Jeha, Mary V. Relling, Allen Eng-Juh Yeoh, Jun J. Yang

Blood (2017) 130 (10): 1209–1212.

https://doi.org/10.1182/blood-2017-05-782383

Published: 2017

Includes: Supplemental data

Journal Articles

Asparaginase May Affect Mercaptopurine Tolerability in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia

Chengcheng Liu, PhD, Deqing Pei, Cheng Cheng, PhD, Jun J Yang, PhD, Kristine R Crews, PhD, John C Panetta, PhD, Xiangjun DeMeter, Sima Jeha, MD, John Sandlund, MD, Raul C. Ribeiro, MD, Jeffrey E Rubnitz, MD PhD, Monika L. Metzger, MD, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2016) 128 (22): 179.

https://doi.org/10.1182/blood.V128.22.179.179

Published: 2016

Journal Articles

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia

Blood (2016) 127 (5): 558–564.

https://doi.org/10.1182/blood-2015-10-673848

Published: 2016

Includes: Supplemental data

Journal Articles

Genome-Wide Association Study Identifies PNPLA3 I148M Variant Associated with Elevated Transaminase Levels after Induction Therapy in Pediatric ALL Patients

Christian A. Fernandez, PhD, Colton Smith, PhD, Wenjian Yang, PhD, Chengcheng Liu, B.S, Laura B. Ramsey, PhD, Seth E. Karol, MD, Ching-Hon Pui, MD, William E. Evans, PharmD, Sima Jeha, MD, Mary V. Relling, PharmD

Blood (2015) 126 (23): 3714.

https://doi.org/10.1182/blood.V126.23.3714.3714

Published: 2015

Journal Articles

Genetic Risk Factors for the Development of Osteonecrosis in Children Under Age 10 Treated for Acute Lymphoblastic Leukemia

Blood (2015) 126 (23): 250.

https://doi.org/10.1182/blood.V126.23.250.250

Published: 2015

Journal Articles

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia

Blood (2015) 126 (15): 1770–1776.

https://doi.org/10.1182/blood-2015-05-643601

Published: 2015

Includes: Supplemental data

Journal Articles

Genome-wide analysis links NFATC2 with asparaginase hypersensitivity

Blood (2015) 126 (1): 69–75.

https://doi.org/10.1182/blood-2015-02-628800

Published: 2015

Includes: Supplemental data

Journal Articles

Glutamate Receptor Polymorphisms Contribute to Glucocorticoid-Associated Osteonecrosis

Blood (2014) 124 (21): 367.

https://doi.org/10.1182/blood.V124.21.367.367

Published: 2014

Journal Articles

Genetic Variation in NFATC2 Is Associated with a Higher Risk of Asparaginase Allergy

Blood (2014) 124 (21): 63.

https://doi.org/10.1182/blood.V124.21.63.63

Published: 2014

Journal Articles

A Murine Model of Asparaginase Allergy

Christian A. Fernandez, PhD, Colton Smith, PhD, Seth E. Karol, MD, Laura B. Ramsey, PhD, Chengcheng Liu, Ching-Hon Pui, MD, Sima Jeha, MD, William E. Evans, PharmD, Fred D. Finkelman, PhD, Mary V. Relling, PharmD

Blood (2014) 124 (21): 2295.

https://doi.org/10.1182/blood.V124.21.2295.2295

Published: 2014

Journal Articles

Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase ( TPMT ) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL)

Chengcheng Liu, Deqing Pei, MS, Cheng Cheng, PhD, Jun J. Yang, PhD, Kristine Crews, PharmD, Wenjian Yang, PhD, Seth E. Karol, MD, Sima Jeha, MD, John T. Sandlund, MD, Raul C Ribeiro, MD, Jeffrey E Rubnitz, MD PhD, Monika L. Metzger, MD MS, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2014) 124 (21): 3722.

https://doi.org/10.1182/blood.V124.21.3722.3722

Published: 2014

Journal Articles

HLA-DRB1 *07:01 is associated with a higher risk of asparaginase allergies

Blood (2014) 124 (8): 1266–1276.

https://doi.org/10.1182/blood-2014-03-563742

Published: 2014

Includes: Supplemental data

Journal Articles

Risk Factors For Acute Pancreatitis In Patients With Acute Lymphoblastic Leukemia

Chengcheng Liu, Deqing Pei, MS, Meenakshi Devidas, PhD, Cheng Cheng, PhD, Wenjian Yang, PhD, Scott C. Howard, MD, Mignon L. Loh, MD, Paul L. Martin, MD, PhD, Naomi J. Winick, MD, William Paul Bowman, MD, Eric C. Larsen, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Deepa Bhojwani, MD, Sima Jeha, MD, Ching-Hon Pui, MD, William E. Evans, PharmD, Stephen P. Hunger, MD, Mary V. Relling, PharmD

Blood (2013) 122 (21): 3868.

https://doi.org/10.1182/blood.V122.21.3868.3868

Published: 2013

Journal Articles

HLA-DRB1*07:01 Is Associated With Asparaginase Allergies In Children With Acute Lymphoblastic Leukemia

Blood (2013) 122 (21): 60.

https://doi.org/10.1182/blood.V122.21.60.60

Published: 2013

Journal Articles

Estradiol Promotes Hematopoietic Recovery of HSCT in Mice by Improving Bone Marrow Microenvironment

Gexiu Liu, Chengcheng Liu, Aizhen Zhu, Jing Lai, Xiaoyu Chen, Dongmei He

Blood (2012) 120 (21): 4662.

https://doi.org/10.1182/blood.V120.21.4662.4662

Published: 2012

Journal Articles

The Bone Marrow Adipogenesis During Myeloablative Period and Early Stage of HSCT in Mice Treated by Irradiation or Myeloablative Drugs

Chengcheng Liu, Aizhen Zhu, Jing Lai, Xiaoyu Chen, Dongmei He, Gexiu Liu

Blood (2012) 120 (21): 4664.

https://doi.org/10.1182/blood.V120.21.4664.4664

Published: 2012

Journal Articles

Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia

Jitesh D. Kawedia, Chengcheng Liu, Deqing Pei, Cheng Cheng, Christian A. Fernandez, Scott C. Howard, Dario Campana, John C. Panetta, W. Paul Bowman, William E. Evans, Ching-Hon Pui, Mary V. Relling

Blood (2012) 119 (7): 1658–1664.

https://doi.org/10.1182/blood-2011-09-381731

Published: 2012

Includes: Supplemental data

Journal Articles

Clinical Utility and Implications of Asparaginase Antibodies in Acute Lymphoblastic Leukemia

Chengcheng Liu, Jitesh D. Kawedia, PhD, RPh, Cheng Cheng, PhD, Deqing Pei, MS, Christian A Fernandez, PhD, Xiangjun Cai, PhD, Kristine Crews, Sue Kaste, DO, John C Panetta, PhD, W. Paul Bowman, MD, Sima Jeha, MD, John Sandlund, MD, William E. Evans, PharmD, Ching-Hon Pui, MD, Mary V. Relling, PharmD

Blood (2011) 118 (21): 1481.

https://doi.org/10.1182/blood.V118.21.1481.1481

Published: 2011

Journal Articles

Systemic Exposure to Dexamethasone and Asparaginase Affects Risk of Relapse in Children with Acute Lymphoblastic Leukemia

Jitesh D. Kawedia, PhD, RPh, Chengcheng Liu, Deqing Pei, MS, Cheng Cheng, PhD, Christian A Fernandez, PhD, Scott C Howard, MD, MS, Dario Campana, MD, PhD, John C Panetta, PhD, W. Paul Bowman, MD, William E. Evans, PharmD, Ching-Hon Pui, MD, Mary V. Relling, PharmD

Blood (2011) 118 (21): 2550.

https://doi.org/10.1182/blood.V118.21.2550.2550

Published: 2011

NARROW

Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry

Asparaginase May Affect Mercaptopurine Tolerability in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia

Genome-Wide Association Study Identifies PNPLA3 I148M Variant Associated with Elevated Transaminase Levels after Induction Therapy in Pediatric ALL Patients

Genetic Risk Factors for the Development of Osteonecrosis in Children Under Age 10 Treated for Acute Lymphoblastic Leukemia

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia

Genome-wide analysis links NFATC2 with asparaginase hypersensitivity

Glutamate Receptor Polymorphisms Contribute to Glucocorticoid-Associated Osteonecrosis

Genetic Variation in NFATC2 Is Associated with a Higher Risk of Asparaginase Allergy

A Murine Model of Asparaginase Allergy

Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase ( TPMT ) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL)

HLA-DRB1 *07:01 is associated with a higher risk of asparaginase allergies

Risk Factors For Acute Pancreatitis In Patients With Acute Lymphoblastic Leukemia

HLA-DRB1*07:01 Is Associated With Asparaginase Allergies In Children With Acute Lymphoblastic Leukemia

Estradiol Promotes Hematopoietic Recovery of HSCT in Mice by Improving Bone Marrow Microenvironment

The Bone Marrow Adipogenesis During Myeloablative Period and Early Stage of HSCT in Mice Treated by Irradiation or Myeloablative Drugs

Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia

Clinical Utility and Implications of Asparaginase Antibodies in Acute Lymphoblastic Leukemia

Systemic Exposure to Dexamethasone and Asparaginase Affects Risk of Relapse in Children with Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only